Our technology
We are developing a unique neurotechnology to detect changes in brain function incident to cognitive impairment. It will be a combination electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) medical device to provide biomarkers of MCI and dementia earlier, with greater accuracy, convenience, and clarity than alternative solutions.
Physicians are presented with neurophysiological biomarker information to support their clinical assessment and guide recommendations for further screening, interventions, and planning.
If cognitive impairment is detected early and accurately, and an appropriate care plan is implemented, dementia can be delayed and the impact can be reduced.
applications
Augments the standard clinical assessments for dementia.
Provides a unique measure of functional impairment. Can be used in conjunction with tests detecting structural cognitive impairments, for a complete view of the cognitive condition.
A platform technology enabling detection and monitoring of other cognitive impairments such as traumatic brain injury (TBI), schizophrenia, mild depressive disorder, etc.
About us
We are a team of engineers, neuroscientists, and academic researchers working in collaboration with health care practitioners (geriatricians, neurologist, family physicians, and nurses) to solve this problem using unique cutting-edge technology.
Please contact us if you are interested in participating in our clinical research.